GOLDMAN SACHS GROUP INC - AUTOLUS THERAPEUTICS PLC ownership

AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 69 filers reported holding AUTOLUS THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is 0.06 and the average weighting 1.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of AUTOLUS THERAPEUTICS PLC
ValueSharesWeighting
Q2 2024$272,707
-80.2%
78,364
-63.8%
0.00%
Q1 2024$1,380,256
+62.7%
216,341
+64.2%
0.00%
Q4 2023$848,348
+444.9%
131,731
+97.1%
0.00%
Q3 2023$155,693
-29.8%
66,821
-28.3%
0.00%
Q2 2023$221,804
+452.5%
93,195
+327.2%
0.00%
Q1 2023$40,143
+100257.5%
21,817
+15.7%
0.00%
Q3 2022$40
-33.3%
18,851
-10.4%
0.00%
Q2 2022$60
-100.0%
21,039
-94.4%
0.00%
Q1 2022$1,566,000
+96.7%
375,514
+144.8%
0.00%
Q4 2021$796,000
+115.7%
153,421
+172.1%
0.00%
Q3 2021$369,000
-91.5%
56,391
-91.3%
0.00%
-100.0%
Q2 2021$4,319,000
+6443.9%
650,496
+5559.4%
0.00%
Q1 2021$66,000
-48.8%
11,494
-20.1%
0.00%
Q4 2020$129,000
-59.8%
14,385
-47.8%
0.00%
Q3 2020$321,000
-42.2%
27,574
-20.4%
0.00%
Q2 2020$555,000
+141.3%
34,632
-9.8%
0.00%
Q1 2020$230,000
+63.1%
38,388
+258.2%
0.00%
Q4 2019$141,000
-52.7%
10,716
-55.4%
0.00%
Q3 2019$298,000
+8.8%
24,011
+175.4%
0.00%
Q1 2019$274,000
+24.5%
8,720
+30.3%
0.00%
Q4 2018$220,0006,6940.00%
Other shareholders
AUTOLUS THERAPEUTICS PLC shareholders Q2 2023
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 7,346,829$15,723,00027.32%
TFG Asset Management GP Ltd 3,039,381$6,504,0000.78%
Nantahala Capital Management 5,215,788$11,162,0000.72%
Frazier Life Sciences Management, L.P. 3,746,857$8,018,0000.62%
HARBOR CAPITAL ADVISORS, INC. 148,454$318,0000.29%
DAFNA Capital Management LLC 496,150$1,062,0000.29%
Blackstone Inc. 17,985,611$38,4890.14%
Ikarian Capital, LLC 260,087$556,0000.11%
MYDA Advisors LLC 100,000$214,0000.10%
Privium Fund Management B.V. 113,528$253,0000.09%
View complete list of AUTOLUS THERAPEUTICS PLC shareholders